Efficacy and Safety of Trastuzumab-rezetecan in HER2-Expressing Breast Cancer

Clinical trial NCT07358182 · RECRUITING

Trial details

NCT number: NCT07358182
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status: RECRUITING
Study type: OBSERVATIONAL

Trastuzumab-rezetecan HER2-low Breast Cancer HER2-positive Breast Cancer

Start date: 2025-06-01
Primary completion: 2029-06-30
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.